PubRank

V Sobradillo

Author PubWeight™ 25.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 [2002: a good year for turning approach to COPD around]. Arch Bronconeumol 2002 2.65
2 Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease. Eur Respir J 1999 2.44
3 Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009 2.27
4 [Antimicrobial therapy in exacerbated chronic obstructive pulmonary disease]. Arch Bronconeumol 2002 2.03
5 [Costs of chronic obstructive pulmonary disease in Spain. Estimation from a population-based study]. Arch Bronconeumol 2004 1.62
6 Interpretation of quality of life scores from the St George's Respiratory Questionnaire. Eur Respir J 2002 1.48
7 Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest 2001 1.44
8 [Use of antibiotics in exacerbated chronic obstructive pulmonary disease]. Aten Primaria 2001 1.31
9 Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Thorax 2003 1.22
10 [Smoking habits among sixth-year medical students in Spain]. Arch Bronconeumol 2004 0.87
11 [Respiratory symptoms and diagnosis of COPD in smokers of various types to tobacco. Results from the IBERPOC study]. Arch Bronconeumol 2002 0.83
12 [The EPI-SCAN survey to assess the prevalence of chronic obstructive pulmonary disease in Spanish 40-to-80-year-olds: protocol summary]. Arch Bronconeumol 2009 0.83
13 [Usefulness of computerized tomography in the study of pleural effusion with no presumed diagnosis]. Arch Bronconeumol 1997 0.81
14 Influence of three factors on the diagnostic effectiveness of transthoracic needle aspiration in pneumonia. Chest 1995 0.79
15 [Prevalence of and attitudes towards smoking in a population over 40 years of age]. Arch Bronconeumol 2000 0.79
16 [Transthoracic aspiration punction with ultrafine needle in high risk community acquired pneumonia]. Med Clin (Barc) 1993 0.77
17 [Early discharge and home health care program for patients with exacerbated COPD and asthma]. Arch Bronconeumol 2001 0.77
18 [Second consensus statement on the use of antimicrobial drugs in chronic obstructive pulmonary disease exacerbations]. Rev Esp Quimioter 2002 0.77
19 [A multicenter study of the breaking of the smoking habit with nicotine chewing gum in health personnel]. Med Clin (Barc) 1991 0.77
20 Ten years follow up in patients with chronic obstructive lung disease submitted to a programme of pulmonary rehabilitation. J R Soc Med 1978 0.75
21 Low-dose formoterol Turbuhaler (Oxis) b.i.d., a 3-month placebo-controlled comparison with terbutaline (q.i.d.). Respir Med 1998 0.75
22 [Double-blind clinical trial comparing 5 days of dirithromycin versus 7 days of diacetylmidecamycin in acute bronchitis and acute exacerbations of chronic bronchitis]. Enferm Infecc Microbiol Clin 1997 0.75
23 [Second consensus report on the use of antimicrobial agents in exacerbations of chronic obstructive pulmonary disease]. Arch Bronconeumol 2003 0.75
24 [Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): recruitment and field work]. Arch Bronconeumol 1999 0.75
25 [Accreditation requirements for educational programs in respiratory medicine]. Arch Bronconeumol 2003 0.75
26 [Clinical and etiological features of community-acquired pneumonia in the elderly]. Enferm Infecc Microbiol Clin 1994 0.75
27 [Glycolytic metabolism during muscular excerise in chronic broncho-pulmonary disease without hypoxemia (author's transl)]. Bull Physiopathol Respir (Nancy) 1975 0.75
28 [The role of the new quinolones in the treatment and prevention of tuberculosis and other infections caused by mycobacterium]. Enferm Infecc Microbiol Clin 1999 0.75
29 [Spirometry: quality in the respiratory medicine clinics of a public health care area]. Arch Bronconeumol 2002 0.75
30 [Asthma emergencies: can we lower the rate of readmission after discharge?]. Arch Bronconeumol 1999 0.75
31 [The internal consistency and content validity of the Spanish version of the Asthma Autonomy Questionnaire]. Arch Bronconeumol 2000 0.75
32 [Current use, methodology and evaluation of nonspecific bronchial provocation tests in our country]. Arch Bronconeumol 1995 0.75
33 [Dyspnea, chest pain and respiratory insufficiency in a 68-year-old man]. Med Clin (Barc) 1989 0.75
34 [Pleural effusion associated with primary lymphedema: a rare combination. Apropos of a case]. Med Clin (Barc) 1990 0.75
35 [Pneumonia in alcoholic patients: the clinical and etiological characteristics]. Arch Bronconeumol 1994 0.75
36 [Community acquired pneumonia. Reliability of the criteria for deciding ambulatory treatment]. Arch Bronconeumol 1997 0.75
37 [Protected bacteriologic brushing in patients with severe copd]. Arch Bronconeumol 1997 0.75
38 [Compliance with inhalation treatment of patients with chronic obstructive pulmonary disease]. Arch Bronconeumol 2000 0.75
39 [Use of antibiotics in the exacerbation of chronic obstructive pulmonary disease]. Rev Esp Quimioter 2001 0.75
40 [Bronchoconstriction caused by pressurized aerosol]. Med Clin (Barc) 1987 0.75
41 [Amoxicillin and ampicillin in the patient with chronic bronchitis. Comparative study : bacteriological, pharmacological and clinical]. Nouv Presse Med 1975 0.75
42 [Information seeking and decision making in asthmatic patients]. Arch Bronconeumol 1999 0.75